Changes in Hypoxia-Inducible Factor-1 (HIF-1) and Regulatory Prolyl Hydroxylase (PHD) Enzymes Following Hypoxic–Ischemic Injury in the Neonatal Rat

被引:0
|
作者
Hannah X. Chu
Nicole M. Jones
机构
[1] Monash University,Department of Pharmacology, Faculty of Medicine, Nursing and Health Services
[2] UNSW Australia,Department of Pharmacology, School of Medical Sciences
来源
Neurochemical Research | 2016年 / 41卷
关键词
Hypoxia–ischemia; Neonatal brain injury; Hypoxia-inducible factor-1; Prolyl hydroxylase;
D O I
暂无
中图分类号
学科分类号
摘要
Hypoxia leads to activation of many cellular adaptive processes which are regulated by the transcription factor hypoxia-inducible factor-1 (HIF-1). HIF-1 consists of HIF-1α and HIF-1ß subunits and levels of HIF-1α protein are regulated by HIF prolyl-hydroxylase enzymes (PHD1, 2, 3). The aim of the current study was to investigate the expression of HIF-1α and PHDs at various time points after hypoxia–ischemia (HI), using a neonatal rat model of HI brain injury. Sprague–Dawley rat pups (postnatal day 7) were anaesthetized and underwent right carotid artery occlusion and were then exposed to 6 % oxygen for 2.5 h at 37 °C. HI injured animals demonstrated a significant reduction in the size of the ipsilateral hemisphere, compared to sham controls. Protein analysis using western blotting and enzyme-linked immunosorbent assay showed that 24 h after HI, there was a significant increase in PHD3 protein and an increase of HIF-1α compared to controls. At the 72 h time point, there was a reduction in PHD3 protein, which appeared to relate to cellular loss. There were no changes in PHD1 or PHD2 protein levels after HI when compared to age-matched controls. Further studies are necessary to establish roles for the HIF-1 regulatory enzyme PHD3 in brain injury processes.
引用
收藏
页码:515 / 522
页数:7
相关论文
共 21 条
  • [1] Changes in Hypoxia-Inducible Factor-1 (HIF-1) and Regulatory Prolyl Hydroxylase (PHD) Enzymes Following Hypoxic-Ischemic Injury in the Neonatal Rat
    Chu, Hannah X.
    Jones, Nicole M.
    NEUROCHEMICAL RESEARCH, 2016, 41 (03) : 515 - 522
  • [2] A dynamic model of the hypoxia-inducible factor 1α (HIF-1α) network
    Nguyen, Lan K.
    Cavadas, Miguel A. S.
    Scholz, Carsten C.
    Fitzpatrick, Susan F.
    Bruning, Ulrike
    Cummins, Eoin P.
    Tambuwala, Murtaza M.
    Manresa, Mario C.
    Kholodenko, Boris N.
    Taylor, Cormac T.
    Cheong, Alex
    JOURNAL OF CELL SCIENCE, 2013, 126 (06) : 1454 - 1463
  • [3] Targeting Hypoxia-Inducible Factor-1 (HIF-1) Signaling in Therapeutics: Implications for the Treatment of Inflammatory Bowel Disease
    Hirota, Simon A.
    Beck, Paul L.
    MacDonald, Justin A.
    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2009, 3 (01) : 1 - 16
  • [4] Rapid degradation of hypoxia-inducible factor-1α by KRH102053, a new activator of prolyl hydroxylase 2
    Choi, H. J.
    Song, B-J
    Gong, Y-D
    Gwak, W. J.
    Soh, Y.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (01) : 114 - 125
  • [5] The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis
    Pugh, CW
    Ratcliffe, PJ
    SEMINARS IN CANCER BIOLOGY, 2003, 13 (01) : 83 - 89
  • [6] Vasohibin induces prolyl hydroxylase-mediated degradation of hypoxia-inducible factor-1α in human umbilical vein endothelial cells
    Kozako, Tomohiro
    Matsumoto, Noriko
    Kuramoto, Yukako
    Sakata, Akira
    Motonagare, Rie
    Aikawa, Akiyoshi
    Imoto, Masumi
    Toda, Akihisa
    Honda, Shin-ichiro
    Shimeno, Hiroshi
    Soeda, Shinji
    FEBS LETTERS, 2012, 586 (07) : 1067 - 1072
  • [7] Brain-targeted hypoxia-inducible factor stabilization reduces neonatal hypoxic-ischemic brain injury
    Kuan, Chia-Yi
    Chen, Hong-Ru
    Gao, Ning
    Kuo, Yi-Min
    Chen, Ching-Wen
    Yang, Dianer
    Kinkaid, Melissa M.
    Hu, Erding
    Sun, Yu-Yo
    NEUROBIOLOGY OF DISEASE, 2021, 148
  • [8] In vitro ischemia suppresses hypoxic induction of hypoxia-inducible factor-1 by inhibition of synthesis and not enhanced degradation
    Karuppagounder, Saravanan S.
    Basso, Manuela
    Sleiman, Sama F.
    Ma, Thong C.
    Speer, Rachel E.
    Smirnova, Natalya A.
    Gazaryan, Irina G.
    Ratan, Rajiv R.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2013, 91 (08) : 1066 - 1075
  • [9] Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel-Lindau-dependent pathway
    Li, Ching-Hao
    Liao, Po-Lin
    Yang, Ya-Ting
    Huang, Shih-Hsuan
    Lin, Cheng-Hui
    Cheng, Yu-Wen
    Kang, Jaw-Jou
    ARCHIVES OF TOXICOLOGY, 2014, 88 (03) : 659 - 671
  • [10] Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel–Lindau-dependent pathway
    Ching-Hao Li
    Po-Lin Liao
    Ya-Ting Yang
    Shih-Hsuan Huang
    Cheng-Hui Lin
    Yu-Wen Cheng
    Jaw-Jou Kang
    Archives of Toxicology, 2014, 88 : 659 - 671